These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1683666)

  • 1. Leukocyte adhesiveness/aggregation and neuroleptic drug treatment.
    Zemishlany Z; Aizenberg D; Baruch Y; Aronson M
    Int Clin Psychopharmacol; 1991; 6(2):111-5. PubMed ID: 1683666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.
    Orr MW; Knox JM; Allen R; Gelder MG; Grahame-Smith DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):255-9. PubMed ID: 6111333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated adhesiveness/aggregation of peripheral blood leukocytes in patients with major depression.
    Zemishlany Z; Aizenberg D; Klein C; Modai I; Aronson M; Weizman A
    J Affect Disord; 1998 Jul; 50(1):3-9. PubMed ID: 9716272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukergy test in patients with ischemic heart disease.
    Berliner S; Sclarovsky S; Lavie G; Pinkhas J; Aronson M; Agmon J
    Am Heart J; 1986 Jan; 111(1):19-22. PubMed ID: 3946151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenomenon of leukergy (leukocyte adhesiveness/aggregation): a powerful investigative tool and a sensitive indicator of inflammation, trauma and stress.
    Berliner S; Aronson M
    Isr J Med Sci; 1991 Mar; 27(3):164-72. PubMed ID: 2016160
    [No Abstract]   [Full Text] [Related]  

  • 8. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA; Laughren T; Chisholm E; Williams BW
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
    Rao ML; Gross G; Strebel B; Bräunig P; Huber G; Klosterkötter J
    Psychiatry Res; 1990 Dec; 34(3):243-57. PubMed ID: 1981623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
    Govitrapong P; Mukda S; Turakitwanakan W; Dumrongphol H; Chindaduangratn C; Sanvarinda Y
    Neurochem Int; 2002 Oct; 41(4):209-16. PubMed ID: 12106771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment.
    Essali MA; Das I; de Belleroche J; Hirsch SR
    Biol Psychiatry; 1990 Sep; 28(6):475-87. PubMed ID: 1977477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs.
    Knox JM; Orr MW; Allen R; Gelder MG; Grahame-Smith DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):261-3. PubMed ID: 6111334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS; Faraone SV; Brown WA
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukergy in inflammatory bowel disease.
    Goldman G; Kahn PJ; Aharonson M; Kariv N; Stadler J; Wiznitzer T
    Dis Colon Rectum; 1988 Nov; 31(11):854-6. PubMed ID: 3180957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment.
    Ramchand R; Wei J; Ramchand CN; Hemmings GP
    Life Sci; 1994; 54(21):1579-84. PubMed ID: 7910931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.